Everyone deserves equal access to medicines.
Cost is a key element limiting access to medicines in the United States and worldwide. We are determined to eliminate this problem through innovative technologies and by challenging the status quo.
Our first target is Insulin, a life-saving medication whose price has risen 500% in the last decade; we plan to manufacture insulin and provide it at the lowest possible price to patients in the US and in other countries.
Join us in our effort to restore some fairness to pharmaceutical access